Decibel

Decibel to Sell its Retail Cannabis Stores to FIKA

Retrieved on: 
Friday, March 22, 2024
Nature, Decibel, AB, The Company, Transaction, Sale, Drug

CALGARY, AB, March 22, 2024 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has entered into a binding agreement for the sale of the assets of its brick-and-mortar retail cannabis operations ("Prairie Records") to 2759054 Ontario Inc. d.b.a FIKA ("FIKA"), for approximately $3.0 million (the "Transaction").

Key Points: 
  • CALGARY, AB, March 22, 2024 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has entered into a binding agreement for the sale of the assets of its brick-and-mortar retail cannabis operations ("Prairie Records") to 2759054 Ontario Inc. d.b.a FIKA ("FIKA"), for approximately $3.0 million (the "Transaction").
  • Prairie Records is comprised of three cannabis stores in Alberta and three cannabis stores in Saskatchewan.
  • "Decibel remains committed to our core mission of delivering exceptional cannabis brands and products in Canada and around the world.
  • "Prairie Records continues to hold its place as one of the most unique and beloved cannabis retail brands in Canada.

Decibel Announces Third Quarter Results with $30.2 Million of Net Revenue, $6.7 Million of Adjusted EBITDA, and Positive Free Cash Flow

Retrieved on: 
Thursday, November 16, 2023
EBITDA, Seating assignment, Ageing, Vox, The Company, AB, EPS, Growth, National Market System, Earnings per share, Pharmaceutical industry, Video game, Bank, Decibel

National Market Share(2) of 7.5% in Q3 2023 which placed Decibel as the 2nd largest licensed producer in Canada by market share.

Key Points: 
  • National Market Share(2) of 7.5% in Q3 2023 which placed Decibel as the 2nd largest licensed producer in Canada by market share.
  • Net Revenue of $30.2 million in the third quarter of 2023, with a sequential decline of 2% over the prior quarter, and year over year growth of 65%.
  • Positive Free Cash Flow(1) of $1.2 million in the third quarter of 2023, with a sequential increase of 152% over the prior quarter and a year over year decline of 50%.
  • Adjusted Net Income was negatively impacted by a litigation expense of $3 million related to arbitration that is now concluded.

Decibel Launches General Admission 'Blinker' Closed Loop Vape System

Retrieved on: 
Wednesday, October 4, 2023
Clogging, AB, Stock, Seating assignment, Automotive lighting, Love, Decibel, The Company, Herbal cigarette, Tobacco

CALGARY, AB, Oct. 4, 2023 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a leading manufacturer of cannabis ready to consume products, is pleased to announce the launch of General Admission 'Blinker' closed loop vape system of products.

Key Points: 
  • CALGARY, AB, Oct. 4, 2023 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a leading manufacturer of cannabis ready to consume products, is pleased to announce the launch of General Admission 'Blinker' closed loop vape system of products.
  • "Blinker positions Decibel to meet consumer demand for a better vape experience that delivers bold flavours, smart innovation, best-in-class airflow and superior reliability in performance" said Warren Matzelle, Chief Marketing and Product Officer.
  • "The game-changing Blinker vape system features industry-leading innovation to address the many consumer pain points with existing vape products in today's market.
  • Decibel welcomes you to discover more about the future of vaping with the General Admission Blinker closed loop vape system, please visit www.generaladmission.ca/blinker
    The initial products expected to be launched for the General Admission Blinker system are:
    Key Highlights of the General Admission Blinker System include:
    Large initial assortment of flavours and SKUs which consumers have shown to love in other formats like infused pre-rolls, 510 vape cartridges and edibles
    Blinker vape batteries will be priced in-line with standard 510 batteries, making the system comparable in cost to the 510 system for consumers
    Smart pod technology reduces common vape issues like, clogging and leaking, with best-in-class airflow, vapour production and flavour

Decibel Confirms Resignation of Director

Retrieved on: 
Friday, September 29, 2023
AB, The Company, Policy, Decibel, Management

CALGARY, AB, Sept. 29, 2023 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), today announced that it has accepted the resignation of Paul Wilson in respect of his position as a director of the Company.

Key Points: 
  • CALGARY, AB, Sept. 29, 2023 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), today announced that it has accepted the resignation of Paul Wilson in respect of his position as a director of the Company.
  • At the Company's July 5, 2023 annual general meeting, Mr. Wilson did not receive a majority of votes "FOR" his election as a director and, in accordance with the Company's Majority Voting Policy, Mr. Wilson tendered his conditional resignation as a director of the Company.
  • After careful consideration, the Board of Directors of the Company (the "Board") has decided to accept such resignation.
  • The Company's compensation, corporate governance and nominating committee regularly reviews the composition of the Board and, in light of Mr. Wilson's resignation, will do so with a view towards potentially adding a qualified individual that would complement Decibel's position as a leader in Canadian cannabis industry.

Loud sounds at movies and concerts can cause hearing loss, but there are ways to protect your ears

Retrieved on: 
Tuesday, September 26, 2023
Music, Hobby, Travel, Ear, Noise, Hearing loss, Tinnitus, Ageing, Table tennis rubber, Android, Brain, Cell, Firearm, Explosion, IPhone, Patient, Time, Risk, Hearing, SLM, Korea Disease Control and Prevention Agency, Decibel, Gunshot, Sound, Apple, Center, Hyperacusis, NIOSH, Environment, Huber loss, Motorcycle, Dentistry, Fireworks, Personal protective equipment, Mobile phone

You may not realize it while it’s happening, but ongoing exposure to loud sounds at these venues can damage your hearing.

Key Points: 
  • You may not realize it while it’s happening, but ongoing exposure to loud sounds at these venues can damage your hearing.
  • Even very short exposures to high-level sounds – that’s anything above 132 decibels – can cause permanent hearing loss for some people.
  • And whether from movies or concerts, fireworks or lawn mowers, about 40 million Americans have hearing problems from loud noise exposure.
  • Injuries to the ear from loud sound can cause difficulty hearing, decreased tolerance of loud sounds – also known as hyperacusis – and tinnitus, a constant ringing in the ears.

Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss

Retrieved on: 
Monday, September 25, 2023
STRC, Centerview Partners, CVR, Doctor of Philosophy, Hearing loss, Eastern Time Zone, Congenital hearing loss, European Medicines Agency, Gene editing, Clinical trial, GAAP, AAV, Wilmer Cutler Pickering Hale and Dorr, Wachtell, Lipton, Rosen & Katz, Gene silencing, Biologics license application, GJB2, Acquisition, Patient, CVR Partners, Computershare, Biology, Medicines and Healthcare products Regulatory Agency, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Regeneron Pharmaceuticals, Decibel

TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs.

Key Points: 
  • TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs.
  • The acquisition of Decibel builds on prior collaboration between the companies and includes three ongoing gene therapy programs targeting different forms of congenital, monogenic hearing loss.
  • Preclinical programs include AAV.103 for people with GJB2-related hearing loss and AAV.104 for people with stereocilin (STRC)-related hearing loss.
  • Following its acceptance of the tendered shares, Regeneron completed its acquisition of Decibel through a second step merger of Symphony Acquisition Sub, Inc., with and into Decibel.

Decibel Engages ICP Securities Inc. as its Market Maker and Global One Media's Social Media Services

Retrieved on: 
Friday, September 22, 2023
Gen, AB, Spotify, USD, Generation Z, Millennials, Decibel, The Company, ICP, Social media, Lease

Decibel is equally as pleased to announce it has engaged the services of Global One Media Limited ("Global One Media") to manage its social media channels, including the distribution of interviews, company news, and other similar services.

Key Points: 
  • Decibel is equally as pleased to announce it has engaged the services of Global One Media Limited ("Global One Media") to manage its social media channels, including the distribution of interviews, company news, and other similar services.
  • There are no performance factors contained in the agreement and ICP will not receive shares or options as compensation.
  • Under its agreement with Decibel, Global One Media will receive compensation of USD $3,700 per month.
  • There are no performance factors contained in the agreement and Global One Media will not receive shares or options as compensation.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOVO, DBTX, DM, ZYNE

Retrieved on: 
Thursday, September 7, 2023
Metal, Desktop Metal, Campbell Soup Company, Sale, Harmony, Regeneron Pharmaceuticals, Advertising, Fraud, NYSE, Security (finance), Stratasys, Decibel

If you are a Sovos Brands shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Sovos Brands shareholder, click here to learn more about your rights and options .
  • If you are a Decibel shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Moore Kuehn Encourages SOVO, DBTX, DM and ZYNE Investors to Contact Law Firm

Retrieved on: 
Thursday, September 7, 2023
Campbell Soup Company, PLLC, Wall Street, Desktop Metal, Regeneron Pharmaceuticals, Fraud, Therapy, Bank, Security (finance), Sovo, Stratasys, Decibel

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX

Retrieved on: 
Tuesday, September 5, 2023
Class Action Lawsuit, Professional Services, Legal, CVR, KSF, Sale, Decibel

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Decibel Therapeutics, Inc. (NasdaqGS: DBTX) to Regeneron Pharmaceuticals, Inc. (NasdaqGS: REGN).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Decibel Therapeutics, Inc. (NasdaqGS: DBTX) to Regeneron Pharmaceuticals, Inc. (NasdaqGS: REGN).
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • Please note that the merger is structured as a tender offer, such that time may be of the essence.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .